NEW YORK, Nov. 28 – Biotechnology company Pluvita has signed a three-year, non-exclusive deal for access to AxCell Bioscience’s ProChart database, which contains information on signal transduction pathways in the human proteome, AxCell said Wednesday. Financial terms of the deal were not disclosed.

The database includes the map of the WW protein domain family, a complete human domain family involved in signal transduction. ProChart also includes protein pathway information from several other domain families, such as PDZ, SH2 and SH3.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.